Although natural killer (NK) cells, a key component of the innate immune system, have been identified in human and mouse atherosclerotic lesions, their role in atherosclerosis development remains unclear. To determine their role in atherosclerosis, we used both loss-and gain-of-function experiments in ApoE 2/2 mice fed a high-fat diet. 
Introduction
Atherosclerosis is a chronic inflammatory disease of elastic and large muscular arteries, characterized by lesions containing cholesterol, immune cells, smooth muscle cells, and necrotic cores. Macrophages, dendritic cells, and T cells are major immune cells populating developing lesions, but other less-abundant immune cell types such as natural killer T (NKT) cells and NK cells are also present. 1 NK cells are bone marrowderived lymphocytes that act as effectors, through cell-mediated cytotoxicity, by releasing perforin and granzymes and/or cytokines such as interferon-g (IFN-g). 2 NK cells sense pathological changes or stressed cells via activating receptors. 3 These cells have been detected in human atherosclerotic lesions. 3, 4 In more advanced atherosclerotic lesions, 5 these cells are frequently localized to regions near necrotic cores deep within plaques and also in shoulder regions. 5 NK cells have also been detected in atherosclerotic lesions of mice. 6 These cells have the potential to modulate atherosclerosis via NK-activating receptors that recognize MHC class I molecules including homologues such as MICA and MICB. 7 Despite such studies, the role of NK cells in atherosclerosis is still unclear.
Early studies on the role of NK cells in atherosclerosis using a beige mutation in mice suggested an atheroprotective role. 8 Beige-mutant mice have a defect in lysosomal fusion/fission and trafficking and the deficiency causes defects in cytolytic function of NK cells. 9 The beige mutation in mice involves the Lyst gene implicated in lysosomal trafficking. The gene product is a homologue of the protein implicated in autosomal-recessive † Present address. Department of Physiology, Monash University, Clayton, Victoria, Australia. ‡ B.-H.T. and A.B. contributed equally.
human Chediak-Higashi syndrome and results in a complex phenotype of partial albinism, immunodeficiency, bleeding diathesis, and neuropathy. 10 Defects in cell function are, however, not restricted to NK cells, but also include neutrophils and other cells, making it unclear whether the increase in atherosclerosis in Lyst-beige LDLR 2/2 mice is a consequence of impaired NK cell function. 11 Subsequently, Ly49A transgenic mice were used to assess NK cell function in atherosclerosis. 6 These mice overexpress the inhibitory receptor Ly49A under the granzyme A promoter; 12 consequently, all splenic NK cells and approximately half the T cells express Ly49A. In addition, mature NK cell populations are reduced by 70%, most likely due to insertion of the transgene into the ATF2 locus. 13 Transfer of bone marrow from Ly49A transgenic mice into LDLR 2/2 mice resulted in attenuated atherosclerosis. 6 While the authors concluded that impaired activity of NK cells is responsible for the attenuated atherosclerosis, the possibility that T cells known to express granzyme A and whose functions are affected by Ly49A, notably NKT cells 14 and CD8 + T cells, 15 also contribute to the reduction in atherosclerosis was not excluded. We have previously shown that NKT and CD8 + T cells augment atherosclerosis development. 14, 16 Because of the complexities in previous animal models used to define the role of NK cells in atherosclerosis, we have re-investigated their significance for atherosclerosis by performing both loss-and gain-of-function studies. Loss-of-function studies were performed by depleting NK cells in high-fat diet (HFD)-fed ApoE-deficient mice using anti-Asialo-GM1 antibodies. Asialo-GM1 is expressed on NK cells and anti-Asialo-GM1 antibodies deplete NK cells without affecting NKT cells. 17 Gain-of-function studies were performed by transferring purified NK cells into ApoE 2/2 Rag2 2/2 IL2rg 2/2 mice, which are deficient in all lymphocytes including NK, NKT, T, and B cells. 18 Using these two mouse models, we provide novel insights into how NK cells augment atherosclerosis.
Methods
Expanded materials and methods are available in Supplementary material online.
Animals and treatments
Male apolipoprotein E gene knockout (ApoE 2/2 ) mice and ApoE 
Cholesterol analysis
Plasma cholesterol levels were determined as described previously. 
mRNA extraction and real-time PCR
mRNAs extracted from isolated cells (NK cells or macrophages) and aortic arches were analysed for the expression of perforin, granzyme B, ApoE using real-time PCR, as described previously. 16, 18 
Statistics
Statistical analyses were performed using Student's t-test when data followed a normal distribution or the Mann-Whitney U test when data did not follow a normal distribution. Normality was determined using the D'Agostino and Pearson omnibus normality test. One-way ANOVA was used to compare more than two groups. Analyses were performed using GraphPad Prism v5.02. P , 0.05 was statistically significant.
Results

Anti-Asialo-GM1 treatment depletes NK cells in ApoE 2/2 mice
Initially, we examined the effectiveness of the anti-Asialo-GM1 antibody treatment for depleting NK cells in peripheral blood. Five days after a single dose of anti-Asialo-GM1 antibody, NK cells in blood were reduced by .90% (P , 0.05; Figure 1A ). Identical effects on blood NK cells were observed after treating ApoE 2/2 mice fed an HFD for 8
weeks (P , 0.05; Figure 1B ). To confirm the specificity of the treatment, NK cells and atherosclerosis we also examined the effects on splenic lymphocytes. At this time, despite having similar spleen weights between the two groups (P . 0.05; data not shown), NK cells per spleen were reduced by almost 60% (P , 0.05; Figure 1C ), whereas other lymphocytes, CD4 + , CD8 + T cells, CD22 + B cells, and NKT cells, were unaffected (P . 0.05; Figure 1C ). lesions determined by ORO staining were reduced by 62% compared with mice administered with control normal rabbit serum (NRS) (P for difference ,0.05; Figure 2A ). Macrophage accumulation was also reduced by 60% compared with lesions from control mice (P , 0.05; Figure 2B ). Lesion MCP-1 expression was reduced (P , 0.05; see Supplementary material online, Figure S1 ). Lesion smooth muscle cells, mostly associated with the fibrous cap, were unaffected (P . 0.05; Figure 2C ), and the reduction in CD4 + T cells was not statistically significant (P . 0.05; Figure 2D ); VCAM-1 expression was unaffected (P . 0.05; Figure 2E ). Body weights were similar in the two groups, averaging 28.3 + 0.6 g (n ¼ 9) and 28.2 + 0.6 g (n ¼ 8), as were blood cholesterol levels, 16.2 + 1.9 (n ¼ 9) and 13.7 + 2.5 (n ¼ 8) mmol/L (P . 0.05). Thus, the attenuation in lesion size in the anti-Asialo-GM1 antibodytreated mice is due to reduced NK cell numbers and is independent of cholesterol levels. Figure 4A and C); on average, lesion size was doubled by NK cell transfer. Macrophage accumulation in lesions also increased to a similar extent (P , 0.05; Figure 4B and D). Plasma cholesterol levels and body weights were largely unaffected by adoptive transfer of NK cells ( Figure 3C ). Four weeks after adoptive transfer of IFN-g-deficient, perforin-deficient, and granzyme B-deficient NK cells to ApoE 2/2 Rag2 2/2 IL2rg 2/2 mice, liver NK cells were markedly elevated ( Figure 3C ), similar to the transfer of WT NK cells ( Figure 3A) . Adoptively transferred NK cells deficient in IFN-g also increased atherosclerotic lesions compared with control mice, to a similar extent as WT NK cells ( Figure 4A and C ) . Macrophage accumulation was also increased (Figure 4B and D) . In contrast, adoptive transfer of NK cells deficient in perforin or granzyme B did not increase lesion size, which was similar to that in control mice that received vehicle (P . 0.05; Figure 4A and C). Macrophage accumulation was also similar to that in lesions in control mice (P . 0.05; Figure 4B and D). Plasma lipid levels and body weight were largely unaffected by the NK cell transfer ( Table 1) .
NK cell depletion by anti-Asialo-GM1 attenuates atherosclerosis in hyperlipidaemic ApoE
NK cell and necrotic core development
Accumulation of apoptotic cells within atherosclerotic lesions due to impaired efferocytosis contributes to necrotic core development and post-apoptotic necrosis, resulting in accelerated atherosclerosis. 23 -25 Since perforin and granzyme B released by NK cells induce target cell apoptosis, 22 we next determined the extent to which NK cell-derived perforin and granzyme B contributed to necrotic core development in lesions of ApoE Figure 5A -B). In contrast, necrotic core size was unaffected in lesions of mice that had received NK cells deficient in either perforin or granzyme B (P for difference .0.05; Figure 5A and B). Figure 5C ) and in close proximity to macrophages in atherosclerotic lesions ( Figure 5D ).
NK cells home to atherosclerotic lesions
Discussion
Using two independent experimental approaches involving loss-and activation by disrupting T-cell receptor signalling. 26 As CD4 + T-cell activation has also been implicated in atherosclerosis development, 27 inhibitory effects on CD4 + T-cell activation could contribute to the attenuated atherosclerosis in such mice. Also, the position of incorporation of the Ly49A transgene could also directly contribute NK cells and atherosclerosis NK cells and atherosclerosis to attenuated atherosclerosis independently of effects on lymphocyte activation. In donor Ly49A transgenic mice, NK cell development is arrested due to insertion of the transgene into the ATF2 locus, resulting in the expression of a truncated ATF2 transcript. 13 Reductions in active ATF2 in endothelial cells suppress basal pro-inflammatory gene expression 28 and may also affect pro-inflammatory cytokine secretion by T cells. 29 In contrast to these studies, LDLR 2/2 mice expressing the beige mutation, which also affects NK cell function, exhibit accelerated Results are means + SEM and the number of mice in each group is in parenthesis. VLDL, LDL, and HDL indicate very low-density, low-density, and high-density lipoprotein, respectively. *P , 0.05.
atherosclerosis. 8 This effect was not attributed to interactions with B or T cells as atherosclerosis was accelerated in LDLR 2/2 Rag1 2/2 mice expressing the beige mutation. Since NK cells are not depleted, it has been suggested that the beige mutation is affecting a yet to be defined NK cell function to affect atherosclerosis development. However, more recent studies indicate that this atheroprotective effect is dependent on the presence of the beige mutation in bone marrowderived cells, endothelial cells, and vascular smooth muscle cells. 30 In the present study, we avoided such complexities by directly demonstrating that NK cells promote atherosclerosis. Specific depletion of NK cells by the anti-Asialo-GM1 antibody attenuated atherosclerosis consistent with NK cells augmenting development of atherosclerosis; 16 raising the possibility that such a mechanism may be common to other cytotoxic immune cells. Human NK cell numbers and their activity were reduced in patients with coronary artery disease. It was not clear whether medications such as statin and b1-receptor blocker could have affected NK cell function. 46, 47 In conclusion, our loss-and gain-of-function studies of NK cells in the development of atherosclerosis have definitively shown that NK cells are atherogenic. Their production of the cytotoxins perforin and granzyme B and expansion of necrotic cores within lesions contribute to atherosclerosis development. Our finding that in immune-intact ApoE 2/2 mice NK cells appear to contribute to a greater extent to atherosclerosis than in lymphocyte-deficient ApoE 
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